KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Restructuring Costs (2016 - 2024)

Historic Restructuring Costs for Bausch Health Companies (BHC) over the last 16 years, with Q4 2024 value amounting to -$2.0 million.

  • Bausch Health Companies' Restructuring Costs rose 3333.33% to -$2.0 million in Q4 2024 from the same period last year, while for Sep 2024 it was -$1.0 million, marking a year-over-year decrease of 11666.67%. This contributed to the annual value of $33.0 million for FY2022, which is 312.5% up from last year.
  • As of Q4 2024, Bausch Health Companies' Restructuring Costs stood at -$2.0 million, which was up 3333.33% from $2.0 million recorded in Q3 2024.
  • Bausch Health Companies' 5-year Restructuring Costs high stood at $13.0 million for Q2 2022, and its period low was -$3.0 million during Q4 2023.
  • Moreover, its 5-year median value for Restructuring Costs was $5.0 million (2021), whereas its average is $5.4 million.
  • In the last 5 years, Bausch Health Companies' Restructuring Costs skyrocketed by 23333.33% in 2020 and then plummeted by 20000.0% in 2023.
  • Over the past 5 years, Bausch Health Companies' Restructuring Costs (Quarter) stood at $10.0 million in 2020, then grew by 20.0% to $12.0 million in 2021, then plummeted by 75.0% to $3.0 million in 2022, then crashed by 200.0% to -$3.0 million in 2023, then soared by 33.33% to -$2.0 million in 2024.
  • Its last three reported values are -$2.0 million in Q4 2024, $2.0 million for Q3 2024, and -$3.0 million during Q4 2023.